Tag: funding

  • Vaccinology and reproducibility

    Uncategorized | Jackie Hunter

    Well a bit of a shock to the system to be back at work but it certainly beats squelching around in a very wet and muddy garden.

    Our beagle had another fit at the weekend which continues to remind me of the importance of the One Health agenda. I was talking at the inaugural meeting of the Veterinary Vaccinology Network in Manchester last week on the subject of open innovation and its potential for veterinary vaccinology. […]

  • Ending 2015 on a high

    Uncategorized | Jackie Hunter

    This is the last blog from me for 2015 but I think we have finished the year on some real highs both for BBSRC and for all Research Councils. For example last Friday we got the official notification from BIS that work can commence on the new Centre for Food and Health at Norwich. The new centre will focus on the role of the microbiome and the importance of diet and nutrition in health and wellness. A conference in the UK is planned in the second quarter of next year with the New York Academy of Sciences on the microbiome and the programme is already shaping up to be very exciting. […]

  • Basic research investment produces impact

    Uncategorized | Jackie Hunter

    It is always pleasing to see our investments in the research base bearing fruit whether it be in excellent publications or social and economic impact. So the announcement by GlaxoSmithKline (GSK), the Wellcome Trust Sanger Institute and the European Bioinformatics Institute of the creation of a new Centre for Therapeutic Target Validation (CTTV) at Hinxton was very welcome. The new CTTV will aim to address a wide range of human diseases and will share its data openly in the interests of accelerating drug discovery. This new centre will employ up to 50 people from the partner organisations but longer term will involve other organisations and companies who are interested in this area. It was particularly good to receive confirmation from Patrick Vallance, President of R&D at GSK, that their decision to base the CTTV in the UK was influenced by their recognition of the UK’s world class capabilities and skills in the areas of genomic, data mining and translational research. Much of this capability has been built using BBSRC funding for basic research in bioinformatics and genomics, along with other funders such as the Wellcome Trust and MRC. The CTTV will itself be based in the EBI South Building, home of the ELIXIR Hub and built with Research Council funding led by BBSRC. […]

  • Health and future wellbeing

    Uncategorized | Jackie Hunter

    Gastro-intestinal track research has huge importance for health and wellbeing – and is an exciting area of science. My view was reinforced last week when I paid a visit to the Institute for Food Research at Norwich and heard some great talks by its research faculty. Phylogenomics and molecular approaches to food borne pathogens such as Salmonella species, protein polysaccharides interactions and their impacts on immune cell function, kinase ligands as important targets for dietary polyphenols and the characterisation of gut microbiota in early infancy were just some of the topics on the menu. Over recent years, interest has grown in the effects of diet on gut microbiota, the impact of microbiota on brain and behaviour as well as the interplay between the gut microbiota and disease states such as obesity. […]

  • A busy, festive run-up to Christmas

    Uncategorized | Jackie Hunter

    The last few weeks before Christmas have been very busy with meetings with Chief Executives of the other Research Councils, partnership meetings with industry, BIS and other public bodies, as well as presentations and talks.

    I attended a council meeting of the Society of Biology and agreed with members around the table that we should explore other areas where we could work more closely together.

    The highlight of the past two weeks (apart from my daughter’s graduation!) was the official launch of ELIXIR in Brussels on 18 December. This marked the transition of ELIXIR to an operational phase as Europe’s sustainable infrastructure for biological data. […]